Cargando…

Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method

The durability of bioprosthetic heart valves is always compromised by the inherent antigenicity of biomaterials. Decellularization has been a promising approach to reducing the immunogenicity of biological valves. However, current methods are insufficient in eliminating all immunogenicity from the b...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Mingzhe, Yi, Liang, Tang, Zhenjie, Xie, Xinlong, Liu, Yuhong, Qi, XiaoKe, Jiang, Zhenlin, Chen, ZeGuo, Chen, Chunyang, Wu, QiYing, Wu, ZhongShi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083275/
https://www.ncbi.nlm.nih.gov/pubmed/37051276
http://dx.doi.org/10.3389/fbioe.2023.1141247
_version_ 1785021472240041984
author Song, Mingzhe
Yi, Liang
Tang, Zhenjie
Xie, Xinlong
Liu, Yuhong
Qi, XiaoKe
Jiang, Zhenlin
Chen, ZeGuo
Chen, Chunyang
Wu, QiYing
Wu, ZhongShi
author_facet Song, Mingzhe
Yi, Liang
Tang, Zhenjie
Xie, Xinlong
Liu, Yuhong
Qi, XiaoKe
Jiang, Zhenlin
Chen, ZeGuo
Chen, Chunyang
Wu, QiYing
Wu, ZhongShi
author_sort Song, Mingzhe
collection PubMed
description The durability of bioprosthetic heart valves is always compromised by the inherent antigenicity of biomaterials. Decellularization has been a promising approach to reducing the immunogenicity of biological valves. However, current methods are insufficient in eliminating all immunogenicity from the biomaterials, necessitating the exploration of novel techniques. In this study, we investigated using a novel detergent, fatty alcohol polyoxyethylene ether sodium sulfate (AES), to remove antigens from bovine pericardium. Our results demonstrated that AES treatment achieved a higher pericardial antigen removal rate than traditional detergent treatments while preserving the mechanical properties and biocompatibility of the biomaterials. Moreover, we observed excellent immune tolerance in the in vivo rat model. Overall, our findings suggest that AES treatment is a promising method for preparing biological valves with ideal clinical application prospects.
format Online
Article
Text
id pubmed-10083275
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100832752023-04-11 Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method Song, Mingzhe Yi, Liang Tang, Zhenjie Xie, Xinlong Liu, Yuhong Qi, XiaoKe Jiang, Zhenlin Chen, ZeGuo Chen, Chunyang Wu, QiYing Wu, ZhongShi Front Bioeng Biotechnol Bioengineering and Biotechnology The durability of bioprosthetic heart valves is always compromised by the inherent antigenicity of biomaterials. Decellularization has been a promising approach to reducing the immunogenicity of biological valves. However, current methods are insufficient in eliminating all immunogenicity from the biomaterials, necessitating the exploration of novel techniques. In this study, we investigated using a novel detergent, fatty alcohol polyoxyethylene ether sodium sulfate (AES), to remove antigens from bovine pericardium. Our results demonstrated that AES treatment achieved a higher pericardial antigen removal rate than traditional detergent treatments while preserving the mechanical properties and biocompatibility of the biomaterials. Moreover, we observed excellent immune tolerance in the in vivo rat model. Overall, our findings suggest that AES treatment is a promising method for preparing biological valves with ideal clinical application prospects. Frontiers Media S.A. 2023-03-27 /pmc/articles/PMC10083275/ /pubmed/37051276 http://dx.doi.org/10.3389/fbioe.2023.1141247 Text en Copyright © 2023 Song, Yi, Tang, Xie, Liu, Qi, Jiang, Chen, Chen, Wu and Wu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Song, Mingzhe
Yi, Liang
Tang, Zhenjie
Xie, Xinlong
Liu, Yuhong
Qi, XiaoKe
Jiang, Zhenlin
Chen, ZeGuo
Chen, Chunyang
Wu, QiYing
Wu, ZhongShi
Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method
title Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method
title_full Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method
title_fullStr Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method
title_full_unstemmed Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method
title_short Preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method
title_sort preliminary study of improving immune tolerance in vivo of bioprosthetic heart valves through a novel antigenic removal method
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083275/
https://www.ncbi.nlm.nih.gov/pubmed/37051276
http://dx.doi.org/10.3389/fbioe.2023.1141247
work_keys_str_mv AT songmingzhe preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT yiliang preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT tangzhenjie preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT xiexinlong preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT liuyuhong preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT qixiaoke preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT jiangzhenlin preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT chenzeguo preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT chenchunyang preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT wuqiying preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod
AT wuzhongshi preliminarystudyofimprovingimmunetoleranceinvivoofbioprostheticheartvalvesthroughanovelantigenicremovalmethod